In vivo, CPP20 enhanced the activity of antioxidant enzymes (CAT, SOD, and GSH-Px) and regulated TC, TG, LDL-C, HDL-C, and TBA levels in the serum and liver to relieve symptoms of hypercholesterolemia. This evidence concerns the gene CAT and Hypercholesterolemia.